Nanoparticles have gained significant importance in the past two decades, due to their multifaceted
applications in the field of nanomedicine. As our ecosystems and habitats are changing due to global warming,
many new diseases are emerging continuously. Treating these costs a lot of money and mostly ends up in failure.
In addition, frequent use of antibiotics to control the emerging diseases has led the pathogens to develop resistance
to antibiotics. Hence, the nanoparticles are targeted to treat such diseases instead of the costly antibiotics. In
particular, the biosynthesized nanoparticles have received considerable attention due to their simple, eco-friendly
and promising activity. To highlight, microbial mediated nanoparticles have been found to possess higher activity
and thus have a promising role in antimicrobial therapy to fight against the emerging drug-resistant pathogens. In
this context, this review article is aimed at highlight the role of nanoparticles in the field of nanomedicine and
importance of actinobacteria in the nanoparticle synthesis and their need in antimicrobial therapy. This is a comprehensive
review, focusing on the potential of actinobacteria-mediated nanoparticles in the field of nanomedicine.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.